Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SENORES

SENORES

HealthcarePharmaceuticals & Biotechnology₹5030 cr market cap
₹1105.70 ▲ +1.2% today As of 19 Nov 2026
52-week low ₹710.2552-week high ₹1550.90

-29.6% from the 52-week high · +53.8% above the low

Senores Pharmaceuticals Ltd develops, manufactures, and markets a wide range of pharmaceutical products. The company focuses on tablets, capsules, injectables, and healthcare formulations, catering to domestic and international markets. It emphasizes quality, regulatory compliance, and research-driven product development to support better patient outcomes.

The short version. SENORES reported revenue of ₹192 crore for Sep 2026, up 18.5% from a year earlier. Net profit was ₹39 crore (up 21.9% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 45.82% in Sep 2026, up 0.05 points over 8 quarters.

1 · The price

How has the stock traded?

SENORES trades 29.6% below its 52-week high and 53.8% above its 52-week low.

Change over period: —

1M-12.8%
3M-29.6%
6M+0.8%
1Y+37.0%

2 · The business

Is it growing?

Sales, year on year+18.5%

Sep 2026 revenue of ₹192 cr.

Profit, year on year+21.9%

Sep 2026 net profit of ₹39 cr.

Net margin20.5%

0.5 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue192180175175162138114103
Net profit3931373232201817
Net margin %20.517.020.918.120.014.315.716.7
EPS (₹)8.576.677.966.877.034.283.93.73

Annual

FY2026FY2025
Revenue633398
Net profit12258
Net margin %19.214.6
EPS (₹)26.3912.67

3 · The quality

How well does it turn capital into profit?

Return on equity was 13.0% in Mar 2026.

Profitability · 2 years

Returns and margins

Mar 2026Mar 2025
Return on equity %13.07.4
Return on capital %15.69.3
EBITDA margin %31.726.1
Net margin %17.914.0

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Current ratio1.92
P/E ratio37.3

4 · The owners

Who holds it, and are they adding?

Promoter holding45.82%

Up 0.05 pts over 8 quarters.

Foreign institutions6.01%

Up 1.76 pts over 8 quarters.

Domestic institutions10.84%

Down 0.94 pts over 8 quarters.

Mutual fund schemes30

+14 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter45.7745.7745.7845.7945.845.8245.8245.82+0.05
FII4.254.173.674.283.353.646.626.01+1.76
DII11.789.659.518.619.319.619.7710.84-0.94
Public38.240.441.0441.3141.5440.9337.7937.33-0.87

Mutual fund holdings · Oct 2026

30 schemes hold this stock

16 the month before.

  • Mahindra Manulife Large & Mid Cap Fund1.78% of NAV
  • Bajaj Finserv Healthcare Fund1.65% of NAV
  • Mahindra Manulife Innovation Opportunities Fund1.58% of NAV
  • THE WEALTH COMPANY SMALL CAP FUND1.48% of NAV
  • Bajaj Finserv Consumption Fund1.47% of NAV
  • Mahindra Manulife Balanced Advantage Fund1.37% of NAV
  • Bajaj Finserv Small Cap Fund1.13% of NAV
  • SAMCO SPECIAL OPPORTUNITIES FUND1.04% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for SENORES are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about SENORES

What is the SENORES share price?

SENORES (SENORES) last closed at ₹1,105.70, up 1.2% on the day. Its 52-week range is ₹710.25 to ₹1,550.90.

What is the market cap of SENORES?

SENORES has a market capitalisation of about ₹5,030 crore. Its price-to-earnings ratio is 37.3.

How are SENORES's latest results?

SENORES reported revenue of ₹192 crore for Sep 2026, up 18.5% from a year earlier. Net profit was ₹39 crore (up 21.9% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 45.82% in Sep 2026, up 0.05 points over 8 quarters.

Who owns SENORES?

As of Sep 2026, shareholding was: Promoter 45.82%, FII 6.01%, DII 10.84%, Public 37.33%.

How many mutual funds hold SENORES?

30 mutual fund schemes held SENORES in October 2026. That compares with 16 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.